SCHEMBL8905913

SCHEMBL8905913

COC(=O)C1CCC2CC=CC=C2N1C(=O)C(F)(F)F

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15993770 0.66 NOTUM (0.33)
SCHEMBL8905911 0.65 KMT2A (0.47) KMT2A
SCHEMBL29177032 0.62 MMP2 (0.32)
SCHEMBL2770223 0.62 PEPD (0.43)
SCHEMBL542421 0.61 MMP2 (0.42)
SCHEMBL18016774 0.61 MMP2 (0.42)
SCHEMBL542420 0.61 MMP2 (0.42)
SCHEMBL16611181 0.61 ALDH1A1 (0.43)
SCHEMBL16611180 0.61 ALDH1A1 (0.43)
SCHEMBL27799008 0.60 CHRM2 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5616586-A Tricyclic quinoxalinediones SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1997-04-01 US disclosed
EP-0642508-A1 TRICYCLIC QUINOXALINEDIONES AS GLUTAMATE RECEPTOR ANTAGONISTS SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1995-03-15 EP disclosed
WO-1993008188-A1 TRICYCLIC QUINOXALINEDIONES AS GLUTAMATE RECEPTOR ANTAGONISTS SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1993-04-29 WO disclosed